The United Laboratories International Holdings Limited
ULIHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.16 | 0.47 | 0.21 |
| FCF Yield | 0.00% | 2.52% | 7.41% | 3.80% |
| EV / EBITDA | 7.94 | 9.65 | 5.12 | 4.59 |
| Quality | ||||
| ROIC | 8.49% | 4.97% | 8.58% | 9.43% |
| Gross Margin | 52.19% | 41.59% | 46.61% | 45.68% |
| Cash Conversion Ratio | – | 1.16 | 1.24 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.47% | 17.01% | 18.14% | 16.39% |
| Free Cash Flow Growth | -100.00% | -60.83% | 143.76% | -39.86% |
| Safety | ||||
| Net Debt / EBITDA | -1.53 | -2.29 | -2.04 | -1.45 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.30 | 1.58 | 1.61 | 1.66 |
| Cash Conversion Cycle | 34.42 | 41.78 | 39.06 | 29.17 |